Skye Bioscience (SKYE) Shares Outstanding (Diluted) (2015 - 2026)
Skye Bioscience's Shares Outstanding (Diluted) was 4.96 million in Q2 2026, up 0.1% from 4.96 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Skye Bioscience (SKYE) Shares Outstanding (Diluted) (2015 - 2026) Analysis & Trends
From Q2 2015 onward, Skye Bioscience has reported Shares Outstanding (Diluted) for 45 quarters.
- Shares Outstanding (Diluted) has now increased for ten consecutive years, with a five-year compound annual growth rate of 112.0% (FY2020 to FY2025).
- In earlier years, Shares Outstanding (Diluted) was 4.56 million in FY2024 (+420.8%), 875,755 in FY2023 (+215.4%), 277,635 in FY2022 (+36.6%) and 203,300 in FY2021 (+75.7%).
- The Q2 2026 figure marks the highest quarterly Shares Outstanding (Diluted) in data going back to Q2 2015.
- Compared with a year earlier, Shares Outstanding (Diluted) has increased for 24 straight quarters, with growth averaging 108.6% over the last eight quarters.
- Across the past five years, year-over-year growth in Shares Outstanding (Diluted) ran from 0.1% in Q1 2026 to 895.0% in Q2 2024.
- Per Business Quant data, SKYE's Shares Outstanding (Diluted) in the three quarters before Q2 2026 was 4.96 million (Q1 2026), 4.96 million (Q4 2025) and 4.96 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.56 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 255.20 Mn |
| 10 | Skye Bioscience | 7.07 Mn | 7.07 Mn | - | 4.96 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.96 Mn |
| Mar 31, 2026 | 4.96 Mn |
| Dec 31, 2025 | 4.96 Mn |
| Sep 30, 2025 | 4.96 Mn |
| Jun 30, 2025 | 4.96 Mn |
| Mar 31, 2025 | 4.96 Mn |
| Dec 31, 2024 | 4.56 Mn |
| Sep 30, 2024 | 4.85 Mn |
| Jun 30, 2024 | 4.83 Mn |
| Mar 31, 2024 | 3.50 Mn |
| Dec 31, 2023 | 875,755.00 |
| Sep 30, 2023 | 985,068.00 |
| Jun 30, 2023 | 485,775.00 |
| Mar 31, 2023 | 470,947.00 |
| Dec 31, 2022 | 277,635.00 |
| Sep 30, 2022 | 247,963.00 |
| Jun 30, 2022 | 247,963.00 |
| Mar 31, 2022 | 247,912.00 |
| Dec 31, 2021 | 203,300.00 |
| Sep 30, 2021 | 207,231.00 |
API Access
Skye Bioscience Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=SKYE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "SKYE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=SKYE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();